TriSalus Life Sciences Future Growth
Future criteria checks 5/6
TriSalus Life Sciences is forecast to grow earnings and revenue by 67.1% and 33.6% per annum respectively while EPS is expected to grow by 71.5% per annum.
Key information
67.1%
Earnings growth rate
71.5%
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | 33.6% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 15 Nov 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 68 | -11 | -32 | -29 | 5 |
| 12/31/2025 | 45 | -16 | -13 | -11 | 6 |
| 12/31/2024 | 29 | -32 | -48 | -43 | 6 |
| 9/30/2024 | 27 | -58 | -45 | -44 | N/A |
| 6/30/2024 | 25 | -57 | -56 | -55 | N/A |
| 3/31/2024 | 22 | -68 | -52 | -50 | N/A |
| 12/31/2023 | 19 | -63 | -51 | -50 | N/A |
| 9/30/2023 | 16 | -53 | -50 | -50 | N/A |
| 6/30/2023 | 15 | -59 | -34 | -33 | N/A |
| 3/31/2023 | 13 | -51 | -33 | -32 | N/A |
| 12/31/2022 | 12 | -50 | -33 | -32 | N/A |
| 9/30/2022 | 12 | -32 | -30 | -28 | N/A |
| 12/31/2021 | 8 | -29 | -24 | -23 | N/A |
| 12/31/2020 | 5 | -32 | -16 | -16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TLSI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: TLSI is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: TLSI is expected to become profitable in the next 3 years.
Revenue vs Market: TLSI's revenue (33.6% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: TLSI's revenue (33.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TLSI's Return on Equity is forecast to be high in 3 years time